We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The Department of Justice filed suit against Mallinckrodt in a Massachusetts federal court yesterday for allegedly evading more than $250 million worth of Medicaid rebates for its H.P. Acthar Gel (repository corticotropin). Read More
FDA Commissioner Stephen Hahn told Congress yesterday that India is restricting exports of 13 active pharmaceutical ingredients (API) and the drug formulations made from them to protect its internal supply chain. Read More
The FDA issued a warning letter to KVK-Tech for serious violations at its Newtown, Pennsylvania drug manufacturing facility, including lax data integrity and investigations. Read More
Four of eight complex trial designs submitted in the FDA’s complex innovative trial design (CID) pilot program have been accepted for review, the agency said Monday. Read More
Sandoz has agreed to pay $195 million to settle charges related to the Department of Justice’s three-year antitrust investigation into the generic drug industry, the company announced yesterday. Read More